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Impairment of brain functional connectivity (FC) is thought to be an early event occurring in diseases with cerebral amyloidosis, such as
Alzheimer’s disease. Regions sustaining altered functional networks have been shown to colocalize with regions marked with amyloid
plaques burden suggesting a strong link between FC and amyloidosis. Whether the decline in FC precedes amyloid plaque deposition or
is a consequence thereof is currently unknown. The sequence of events during early stages of the disease is difficult to capture in humans
due to the difficulties in providing an early diagnosis and also in view of the heterogeneity among patients. Transgenic mouse lines
overexpressing amyloid precursor proteins develop cerebral amyloidosis and constitute an attractive model system for studying the
relationship betweenplaque and functional changes. In this study, ArcA transgenic andwild-typemicewere imagedusing resting-state
fMRI methods across their life-span in a cross-sectional design to analyze changes in FC in relation to the pathology. Transgenic mice
show compromised development of FC during the firstmonths of postnatal life comparedwithwild-type animals, resulting in functional
impairments that affect in particular the sensory-motor cortex already in preplaque stage. These functional alterations were accompa-
nied by structural changes as reflected by reduced fractional anisotropy values, as derived from diffusion tensor imaging. Our results
suggest cerebral amyloidosis inmice is preceded by impairment of neuronal networks andwhitematter structures. FC analysis inmice is
an attractive tool for studying the implications of impaired neuronal networks in models of cerebral amyloid pathology.
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Introduction
The occurrence of amyloid plaques in brain parenchyma and
around the cerebral vessels constitutes a hallmark of Alzheimer’s
disease (AD; Iwatsubo et al., 1994). Cerebral amyloidosis involves
the aggregation of A peptides, a cleavage product of the amyloid
precursor protein (APP). In AD, plaque deposits, fibrils, and oli-
gomers of A are considered essential mediators in the patho-
physiological cascade leading to cognitive decline (Mucke and
Selkoe, 2012). A peptides in various forms have been linked to
alterations in cerebral calcium homeostasis (Kuchibhotla et al.,
2008), axonal guidance (Cao et al., 2012), axonal transport,
and/or synaptic signaling (Knobloch et al., 2007a), processes that
ultimately might translate into impaired neural function.
Marked functional impairments have been observed in pa-
tients with AD using fMRI (Greicius et al., 2004; Johnson et al.,
2012). In particular, resting-state fMRI (rs-fMRI) has been exten-
sively used to investigate functional connectivity (FC) as derived
from the apparent synchronicity of the fMRI signal of distinct
brain regions. Human brain appears organized into 10–15 net-
works (Damoiseaux et al., 2006), among which, the default mode
network (DMN) has gained attention in AD due to its colocaliza-
tion with amyloid plaques (Greicius et al., 2003; Buckner et al.,
2005). Additionally, DMN connectivity was reported affected in
subjects at risk of developing AD including patients with mild
cognitive impairment (Rombouts et al., 2005; Sorg et al., 2007),
in cognitively healthy elders with amyloid deposits (Hedden et
al., 2009; Sperling et al., 2009; Sheline et al., 2010b), and in mid-
life carriers of APO 4 risk allele (Sheline et al., 2010a; Canuet et
al., 2012). Elucidating the relationship between plaque deposi-
tion and functional network change in a temporal and spatially
resolved manner is essential for understanding the pathophysio-
logical cascade and may provide an early diagnostic tool. How-
ever, the heterogeneity among AD patients combined with poor
method reproducibility at the individual level, the latency of dis-
ease onset and difficulties to accurately perform early diagnostics
in patients have rendered such studies in humans difficult.
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Animal models of amyloid pathology offer an experimental
platform to studying AD (Gordon et al., 2002). Although the
molecular processes underlying amyloid pathology in animals
have been examined extensively, studies addressing its implica-
tion on brain FC are lacking as fMRI in mice is challenging. We
have assessed the FC in mice across their lifespan, from 1 to 21
months, in a cross-sectional design using rs-fMRI. The ArcA
transgenic mouse model of cerebral amyloidosis has been used,
which overexpresses the human APP protein with the Swedish
and Arctic mutations. The mice show reduced synaptic plasticity
(Knobloch et al., 2007a), and amyloid pathology affecting both
the brain parenchyma and vasculature by 6 months of age (Kno-
bloch et al., 2007b; Merlini et al., 2011). To obtain a structural
correlate for FC changes, we have complemented fMRImeasure-
ments with diffusion tensor imaging. Combining structural and
functional connectivity data in a temporally resolved manner
provides valuable insight into the mechanisms underlying the
alterations observed in mouse models of amyloidosis.
Materials andMethods
Animal preparation. All animal experiments in this study have been per-
formed in adherence to the Swiss law of Animal Protection and were
approve by the Zurich cantonal veterinary office. A total of 38 (17 male,
21 female) transgenic ArcAmice and 36 (12 male and 24 female) wild-
type littermates aged between 1 and 21months were used in this study in
four different age groups (A–D), imaged at 1 and 2months (GroupA), at
5 months (Group B), at 8 and 11 months (Group C), and at 19 and 21
months (Group D). The groups and corresponding group sizes are sum-
marized in Table 1. Animals were housed in standardmouse caging, with
12 h light/dark cycles with food andwater provided ad libitum.Micewere
anesthetized with isoflurane (Abbott) in 1:4 oxygen to air mix at 3% for
induction and 1.4% during measurements administered via a facemask.
Animals were placed on a mouse support with ear bars placed to reduce
animalmotion during the experiments. The body temperature wasmon-
itored with a rectal thermometer and kept at 36.5°C  0.5°C with an
adjustable warm water bath contained in the support. Measurement in-
cluding mouse preparation typically lasted for 45 min. Animals were
measured a second time in a week interval to evaluate reproducibility.
Animals at 11 and 21 months were killed for histology.
MRI. A BioSpec 94/30 animal MRI system (Bruker BioSpin GmbH)
equipped with a 9.4 T magnet with a horizontal bore of 30 cm diameter,
a BGA12S gradient system capable of a maximum gradient strength of
400 mT/m with a 80 s rise time, a 2 2 cryogenic phased-array receive
coil, and a linear volume resonator coil for excitation have been used.
Anatomical images have been recorded using a multislice rapid acquisi-
tion with relaxation enhancement sequence with repetition time (TR)
2500 ms, echo time (TE) 11 ms, effective echo time (TEeff) 33 ms,
pulse angle (PA) 90°, number of averages (NA) 1,matrix dimension
(MD) 180 180, pixel dimensions (V) 111 97 m2, slice thick-
ness (STH) 500 m, interslice distance (ISD) 200 m, and number
of slices (NSl) 12. For fMRI studies gradient-echo echo-planar imag-
ing (EPI) was with TR  1500 ms, TE  9.3 ms, PA  50°, number of
repetition (NR) 500, NA 1, MD 90 70, V 250 220 m2,
STH 500m, ISD 200m,NSl 12. Diffusion tensor imaging was
performed using amultisegmentDTI-EPI sequence, with TR 3000ms,
TE 25 ms, PA 90°, number of segments 4, NA 1, MD 128
128, V 160 130 m2, STH 500 m, ISD 200 m, NSl 12, b
value of 690 s/mm2, and 36 diffusion encoding directions. Shimmingwas
performed using MAPSHIM protocol.
Images processing. Images were preprocessed in SPM05 (FIL Group)
for MATLAB (MathWorks). Functional MR images were realigned, cor-
rected for slice timing and a nonlinear transformation was applied to
match to an in-house EPI template (Fig. 1a,b). The template has been
obtained as the mean of 10 coregistered EPI datasets that have been
recorded in a separate experiment. To obtain enforce bilateral symmetry,
the original and mirrored EPI data have been averaged. Motion correc-
tion was performed using the tools provided by SPM. Temporal variance
was computed voxelwise and averaged between all scans to obtain maps
revealing clusters of high variances in regions associated with large ves-
sels. The signal traces in these clusters were used a regressors in the
voxelwise analysis to account for contributions arising from the vascula-
ture (Fig. 1c). Initially, we also evaluated for a potential influence from
respiration using RETROICOR (Glover et al., 2000), yet observed that it
had negligible effect on the results. Hence, this contribution was not
furthermore considered. The resulting time series for each voxel were
then bandpass filtered using a range between 0.01 and 0.15 Hz (Rest
toolbox, State Key Laboratory of Cognitive Neuroscience and Learning)
forMATLAB.Mean time series were extracted from the regressed images
using an in-house atlas template based on the functional organization of
themouse brainwith 24 different ROIs (Fig. 1d). Functional connectivity
was measured as the Pearson correlation coefficient between mean time
series from each brain region pairs, corrected with Fisher z-transformation
for bounded values.
Fractional anisotropy (FA) was computed from diffusion tensor im-
ages using Paravision 5 (Bruker BioSpin GmbH). Images were converted
toAnalyze7.5 format andnormalized to a reference space using b0 images
with SPM05. Fractional anisotropy values were extracted for selected
regions-of-interest (ROIs).
All unprocessed anatomical, diffusion tensor, and functional images
were made freely available at central.XNAT.org in Analyze7.5 format
(Project ID: fMRI_AD_mouse).
Histology. Animals were deeply anesthetized with ketamine/xylazine,
and transcardially perfused with cold PBS followed by 4% paraformal-
dehyde. Brains were extracted and put in paraformaldehyde overnight.
Brainswere transferred in succession in 10, 20, and 30% sucrose solution,
before being frozen at80°C. Randomly sampled serial sections (cut at
40 m) were collected and stored at 20°C in cryoprotectant solution
Table 1. Number of animals used in the study per age group and genotype, mean tSNR in the S1 sensory cortex, andmean animal motion during fMRI acquisition
Group Genotype Age (month SD) N (female/male) tSNR S1 (SD) Maximummotion (m SD) Variance motion (m2 SD)
A WT 1.56 (0.11) 10 (5/5) 164.2 (20.4) 41 (17) 0.16 (0.17)
A TG 1.5 (0.08) 11 (4/7) 162.1 (34.8) 39 (24) 0.14 (0.13)
A WT 2.63 (0.13) 10 (5/5) 180.8 (14.2) 40 (14) 0.17 (0.11)
A TG 2.67 (0.11) 11 (4/7) 184.1 (12.4) 44 (25) 0.22 (0.29)
B WT 5.48 (0.57) 8 (6/2) 113.4 (16.5) 39 (33) 0.32 (0.22)
B TG 5.53 (0.47) 8 (6/2) 113.2 (15) 47 (44) 0.31 (0.28)
C WT 8.58 (0.15) 9 (6/3) 104.7 (16.5) 44 (21) 0.38 (0.53)
C TG 8.58 (0.15) 9 (6/3) 117.9 (15.5) 30 (14) 0.31 (0.60)
C WT 11.22 (0.02) 9 (6/3) 139 (17.8) 35 (24) 0.18 (0.21)
C TG 11.21 (0.03) 9 (6/3) 154.5 (22.1) 31 (20) 0.59 (0.71)
D WT 19.15 (0.14) 9 (7/2) 102.6 (24.5) 45 (32) 0.51 (0.75)
D TG 19.18 (0.14) 10 (5/5) 101.8 (21.8) 49 (29) 0.59 (0.71)
D WT 21.83 (0.01) 7 (5/2) 146.4 (26.3) 22 (12) 0.07 (0.06)
D TG 21.83 (0.01) 10 (5/5) 173.6 (38) 37 (27) 0.23 (0.41)
WT, Wild-type; TG, transgenic.
Grandjean et al. • rs-fMRI in ArcAModel of Alzheimer’s Disease J. Neurosci., October 8, 2014 • 34(41):13780–13789 • 13781
(50 mmol/L sodium phosphate buffer, pH 7.4, containing 15% glucose
and 30% ethylene glycol; Sigma-Aldrich). The free-floating sections were
treated for 10 min with pepsin (Dako) 0.15 mg/ml in 0.2 N HCl at 37°C.
After three washes in PBS, the pepsin-treated brain sections were then
incubated overnight at 4°C in the primary antibody solution (mouse
monoclonal amyloid-1–16, clone 6E10, diluted 1:1000, Covance) di-
luted in PBS containing 2% normal goat serum and 0.2% Triton X-100.
After three washes in PBS, tissue sections were incubated for 30 min at
RT in biotinylated secondary antibody (diluted 1:500; Jackson Immu-
noResearch Laboratories). A commercial kit (Vectastain Kit; Vector Lab-
oratories) was then used with 3,3-diaminobenzidine (Sigma-Aldrich),
and sections were stained for 5–10 min. After three washes in PBS, sec-
tions weremounted onto gelatinized glass slides and air-dried overnight.
The sections were then dehydrated through ethanol, cleared in xylene,
mounted with resinous mounting medium (EukittTM, Sigma-Aldrich),
and coverslipped. ROI analysis was performed in ImageJ (NIH) to esti-
mate the fractional surface occupied by amyloid plaques by delineating
the cortical regions according to the atlas used for the FC analysis.
Statistics. Statistical analysis was performed using the statistical soft-
ware R 2.13.0 (The R Foundation for Statistical Computing). A linear
mixed model analysis was performed with gender, age, genotype, and
their twofold interactions as fixed effects using lme4 package.We applied
the Fisher’s z-transformation to the response variable. The effects of each
interaction and factor were tested with Likelihood Ratio Tests. Residual
analysis of the mixed models was performed on randomly selected sam-
ples (n  30) with QQ-plots to inspect normal distribution, Tukey–
Anscombe plots for the homogeneity of the variance and skewness, and
scale location plots for homoscedasticity (i.e., the homogeneity of resid-
ual variance). The assumption of normally distributed residuals was con-
sidered plausible in all tested fractional anisotropy samples and in all of
the randomly tested functional connectivity pairs describing cortical in-
teractions. In a post hoc analysis, the changes of correlation per time were
extracted for the following intervals: 1–5 and 5–19months, and contrasts
were used in the mixed-model analysis to test differences in the response
variable between in wild-type and transgenic mice at these intervals.
Multiple comparisonwas correctedwith false discovery rate (FDR) (Ben-
jamini andHochberg, 1995), with q 0.05 for network comparison, and
q 0.15 for voxelwise analysis. Voxelwise maps were further filtered for
statistically significant clusters of 15 voxels or more. The null hypothesis,
i.e., the absence of effect for a given factor or interaction, was rejected
according to the FDR threshold, and is denoted in the text as factor effect
for simplicity (e.g., genotype effect, genotype  age interaction effect,
etc.). Values in plots and images are shown as mean value per group and
error bars represent 1 SD, p values are shown as log10(p value) to
account for the large range of values.
Results
Group description
During the study, a small portion of animals developed comorbidi-
tiesor abnormal structuresobservedwithT2 anatomical images: two
animals with abnormal ventricles (1-month-old transgenic, 19-
month-old transgenic), one animal with focal hypointensity in the
thalamus (1-month-old transgenic). In addition, two wild-type an-
imals had to be killed between measurements at 19 and 21 months
due to age-related events. All animalsmeasuredwere included in the
analysis.
Preprocessing
EPI image deformation induced by the magnetic field inhomo-
geneity was minimal in most scans and was accounted for by the
nonlinear transformation during the coregistration. There was
no apparent difference related to coregistration in the mean im-
ages in the individual groups as illustratedwith 1- and 11-month-
old animals (Fig. 1a,b). Temporal variancemaps revealed clusters
of high variance in areas colocalizing with major blood vessels
(shown with white arrows) and at the brain boundaries (Fig. 1c).
The signal traces were then extracted from these regions and
regressed from the time series for every voxel (to account for
vascular contributions) alongwith themotion parameters, which
led to an effective reduction in variance in region as indicated by
the variance analysis (Fig. 1c).
Development of FC during early months of life
In wild-type mice, the correlation coefficient between rs-fMRI
time series for ROIs located within the parietal and motor corti-
Figure 1. EPI images were normalized to an in-house template using nonlinear coregistration. The mean of the coregistered images are shown for 1-month-old (a) and 11-months-old (b) for
both wild-type and transgenic mice, and illustrate the performance of the coregistration procedure. No visible difference appears between the groups suggesting the validity of the linear and
nonlinear transformation applied. Temporal variance maps revealed clusters with high variance in the brain boundaries and in areas colocalizing with major blood vessels (c, white arrows).
Voxelwise regressionwas performedwith the signal extracted from these regions, leading to reduced variance in these regions. A color-coded atlas templatewas used for network analysis showing
24 ROIs based on the functional organization of the mouse brain (d). The distance of the respective section from bregma in millimeters is indicated.
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ces developed from values in the range of z  0.15–0.32 at 1
month to values of z  0.4–0.89 measured at 5 months of age
(Figs. 2, 3a–c). Similarly, although less pronounced, changes have
been found in cross-correlation between bilateral retrosplenial/
cingulate cortex and the retrosplenial/cingulate with the parietal
cortices (Figs. 2, 3d). The hippocampus (Figs. 2, 3e) displayed
weak correlations with coefficients z 0.5 bilaterally, and z 0.1
with other regions. Correlation did not exceed z  0.3 between
the dorsal and ventral striatum and the cortical regions (Fig. 2).
ArcAmice display impaired age related FC development
Correlation coefficients observed in 1-month-old ArcA mice
were similar to the age-matched wild-type animals across all re-
gions analyzed, the mice developed FC difference with respect to
wild-type between month 1 and 5 for the cortical ROIs (Figs.
2a–c, 3a–c). Statistical analysis of the correlation matrices (Fig.
2h) revealed strong genotype effect for correlations among left
and right medial and posterior parietal cortices, as well as motor
cortices (Fig. 3b,c; posterior parietal cortices p  3.3  109,
motor cortices p  5.1  103). There was no genotype  age
interaction below FDR threshold. Correlations from the parietal
cortices to the motor cortex showed an age effect (Fig. 2h). None
of the correlation pairs, however, showed a gender effect or gen-
der interaction effects below FDR threshold.
The rate of change of the correlation value per month
(Correlation/month) was evaluated using linear regression for
the 1–5 month (Fig. 4a) and 5–19 month intervals (Fig. 4b),
respectively, and displayed reduced rates for several cortical ROIs
in ArcA compared with wild-type mice during the 1–5 month
period, but not during the 5–19 month interval (Fig. 4c). For
example, for the 1–5month period, theCorrelation/month rate
in themedial parietal cortex were 2.7 103 month1 in ArcA
against 6.5 103 month1 in wild-type mice (Fig. 4a,c; differ-
ence: 3.8  103 month1), whereas for the interval 5–19
Figure 2. Network analysis of cortical regions showing cross-correlations inwild-type (bottom, left of FCmatrix) and ArcAmice (top, right of FCmatrix), at 1 (a), 2 (b), 5 (c), 8 (d), 11 (e), 19 (f ),
and 21 (g) months of age. Color-coded values represent the mean Pearson correlation coefficients per group corrected with Fisher z-transformation. The two elements for each cortical area
correspond to ROIs in left and right hemisphere, respectively. Strongest correlations in the wild-type groups are observed between left and right parietal (aPc, mPc, pPc), motor (Mc), and
retrosplenial/cingulate cortex (Rs/Cg). (h) Pairwise mixed-model analysis showing the genotype and age effects below FDR correction threshold. Color-coded values represent the log p value for
each effect ranging from 0 to15, corrected with FDR.
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months the corresponding values were
1.5  104 month1 for ArcA and
1.9  104 month1 for wild-type
mice, respectively (Fig. 4b,c; difference:
3.4  104 month1). The genotype
contrast for the 1–5 month and 5–19
month interval indicated overall statistical
significant differences across cortical
ROIs between wild-type and ArcA mice
during the 5–19months interval, but only
marginal difference during the 1–5
months interval (Fig. 4d).
Seed-based analysis of the left anterior
parietal cortex (Fig. 5) illustrates the
change of cross-correlation from 1month
to 5, 8, and 21 months of age. In both
ArcA and wild-type mice, a seed ROI lo-
cated within the somatosensory S1 cortex
showed weak diffuse correlation with the
adjacent cortex, and little bilateral corre-
lations at 1 month. In wild-type animals,
correlation to the contralateral parietal
cortices increased by 5 months of age
from z  0.25 to 0.6 consistent with the
values from the network analysis dis-
cussed above. In ArcA mice, FC to the
contralateral parietal cortex remained be-
low the threshold value of z 0.1 also at 5,
8, and 21 months of age.
Associated changes in
fractional anisotropy
A genotype effect in FA changes was
found for the minor forceps, the anterior part of the external
capsule, and the anterior internal capsule (Fig. 6b). Age effect on
FA values was widespread in the white and gray matter (data not
shown), while a gender effect was identified for the anterior in-
ternal capsule (Fig. 6c). No factor interaction (e.g., genotype 
age) effect was observed below the FDR threshold. Slope analysis
for the 1–5 month interval indicate that fibers highlighted by the
statistical analysis presented greater rate of FA change per month
(FA/month) in wild-type mice compared with transgenic ani-
mals. ROI analysis illustrates the difference in FA in the anterior
external capsule in both wild-type and transgenic mice (Fig. 6f;
genotype effect: p 1.6 103, age effect: p 1.7 107), but
not in the posterior external capsule (Fig. 6g).
Amyloid plaque deposition starts in the early life stage
Although only anecdotal parenchymal plaques have been de-
tected in brains of 5 months old ArcAmice, amyloid pathology
was densely present in the cortex and hippocampus in 11- and
21-month-old animals (Fig. 7a). Amyloid plaques occupied be-
tween 3.2 and 7.4% of the cortical surface in the different regions
in 11 months ArcAmice, and 11.9 and 18% at 21 months (Fig.
7b). There was however no correlation between the surfaces oc-
cupied by amyloid plaques and bilateral correlation between the
corresponding areas (Fig. 7c; r  0.08). A mixed model analysis
was devised with fractional surface occupied by amyloid deposits as
a responsevariable andFCvalues for the corresponding regions, age,
and cortical region as explanatory effects. FC did not result in a
significant effect, whereas there was a significant age and cortical
region effect (p 6.5 106 and 4.2 103, respectively).
Potential confounds
We have used isoflurane as an anesthetic, which has been shown
to reveal predominantly cortical correlations, whereas medeto-
midine favored the detection of subcortical correlations.We have
titrated isoflurane levels to achieve animal sedation, with lower
doses resulting in excessive motion artifacts. Anesthesia resulted
in breathing rates of 120  15 breaths per min. There was no
apparent difference in breathing rates between age groups or ge-
notypes. Temporal signal-to-noise ratio (tSNR) in the somatosen-
sory cortex was found to vary between functional imaging sessions
(Table 1; Fig. 8c) with animals imaged at 2 and 21 months of age
displaying thehighest tSNRvalues.Therewasnodifferences in tSNR
between wild-type and transgenic animals, or male and females at
any timepoint.Motionderived fromthe realignment algorithmwas
used to assess maximummotion between the three translation vec-
tors, as well as the variance of the motion vectors. No correlation
between tSNR andmotion could be observed. Finally, neither tSNR
nor motion showed statistical significant effect in the linear mixed
model analysis. Variance of the within-subject effect was lower than
the residual variance by two orders ofmagnitude, which is corrobo-
rated with a relatively low correlation in test–retest analysis ranging
between r  0.4 and r  0.58 across cortical pairwise correlations
(Fig. 8a). For example medial parietal cortex bilateral correlation
yielded a test-retest correlation of r 0.48 (Fig. 8b). In comparison,
fractional anisotropy of the external capsule showed similar test–
retest values of r 0.39.
Discussion
Development of FC in the somatosensory and motor cortex, as
derived from the temporal correlation of rs-fMRI signals, occurs
Figure3. Changes in correlation betweenbilateral ROIs. Black triangles represent themean value from transgenic ArcAmice;
gray circles represent the mean value from wild-type controls. Young animals showed low correlation coefficient in cortical
structures in bothwild-type and transgenic animals at 1month of age, increased between 1 and 5months of age in wild-type but
remained low in transgenic animals. Statistics for each effect is indicated below each plot for the respective effects. Genotype
interactioneffectwasobserved in theanterior andposterior parietal cortexbilateral correlation (a,p2.5108;b,p5.5
103), left-to-rightmotor cortex pair (c, p 2.4 104), and retrosplenial/cingulate cortex (d, p 1.3 102,). Therewas
no genotype effect in the hippocampus (e) or limbic regions (f ). Error bars represent1 SD.
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during the firstmonths of life in wild-typemice and appears to be
significantly impaired in age-matched ArcA mice. These func-
tional deficits are observed before and during the early plaque
build-up stage, although there was only marginal decline in FC
after 5 months of age during amyloid plaque buildup. Structural
development, as reflected by FA measurements, also appears to
be affected during the early months. The findings are in accor-
dance with the previous description of amyloid pathology and
Figure 4. Correlation change in function of age in young adulthood (a, 1–5months) andmid-life (b, 5–19months) indicate lower rates in ArcAmice comparedwithwild-type during the early
age in the cortical regions, withcorrelation/month 4.3 103 to 1.3 103 month1 in transgenic animals andcorrelation/month 7.6 103 to 3.4 103 month1 in
wild-typemice controls. In comparison, therewas no substantial changes in correlation over time inmidlife in both ArcAwithcorrelation/month 2 104 to9 104month1 in the
cortical areas, and wild-type mice withcorrelation/month 0 to2 104 month1. The rate difference (c) reveals marked differences between ArcA and wild-type incorrelation/
month rates in the 1–5 months period in the anterior, medial and posterior parietal cortex, and marginal differences in rates during the 5–19 month interval. (d) Post hoc contrast analysis of
differences between ArcA and wild-type between 1 and 5 months (bottom, left corner) and between 5 and 19 (top, right corner) reveals differences in correlation between the parietal cortices
during the 5–19 month interval, but only marginal differences during the 1–5 month period.
Figure 5. Seed-based analysis of the S1 sensory cortex inwild-type (a) and ArcAmice (b). At 1month, both genotype groups showdiffuse andweak cross-correlation between the seed region
and the surrounding voxels in the cortex.Wild-type animals at 5, 8, and 21months show correlationsmarking the delineation of the parietal cortexwith respect to seed. In comparison, ArcAmice
showweak contralateral correlations to the seed. Color-coded values represent the cross-correlation coefficient between the seed and the corresponding voxel ranging from z0.1 to0.5. The
seed ROI is shown in red on the anatomical referenced. Values represent the distance from bregma in millimeters.
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cognitive deficits early in this mouse
model (Knobloch et al., 2007b), and re-
duced synaptic long term potentiation
observed at 3.5 months (Knobloch et al.,
2007a).
The major finding of our study relates
to the early and robust functional changes
occurring in ArcA transgenic mice, ap-
pearing before amyloid deposition as de-
rived from histological analysis and
reported earlier for this animal model
(Knobloch et al., 2007b). The results com-
pare well with growing evidence of early
functional impairments in humans at risk
of developing Alzheimer’s disease, such as
mid-life APO4 carriers (Sheline et al.,
2010a; Canuet et al., 2012) or asymptom-
atic elderly with amyloid deposition
(Hedden et al., 2009; Sperling et al., 2009;
Sheline et al., 2010b), and corroborate the
reported absence of a correlation between
amyloid plaques and functional connec-
tivity in humans (Adriaanse et al., 2014).
In a previous study of FC in APP/PS1
mouse model of AD, Bero et al. (2012) linked regions of high FC
at 3 months in transgenic mice with regions at risk of developing
amyloid plaques later in life, although the temporal dynamics of
the change with respect to amyloid plaque appearance has not
been demonstrated. Their results differ from ours as FC deficits
in ArcA mice appeared already robustly reduced in the early
phase of life, whereas it appeared increased in young APP/PS1
compared with wild-type, further, we could not correlate func-
tional changes to amyloid plaque burden. Yet, given the large
phenotypic variations between mouse models of AD (Balducci
and Forloni, 2011), different FC patterns and dynamics are to be
expected. In fact, a comparative study of FC patterns between
Figure 6. Reference image with anatomical overlay (a). Voxelwise analysis of FA in ArcA andwild-typemice reveals a genotype effect in the corpus callosum, anterior external capsule, minor
forceps and internal capsule (b). A gender effect is found in the left internal capsule (c). Color-coded values represent the log p value corrected with false discovery rate and cluster size15. Rate
of FA change permonth (FA/month) during the 1–5month interval indicates higher rates in wild-type (d) comparedwith ArcAmice (e) for fibers presenting a genotype effect in the voxelwise
analysis. ROI analysis shows themaximumFA value along a line profile across the anterior external capsule (ROI ecant, f; genotype effect: p 1.3 10
3) and posterior external capsule (ROI ecpost,
g) and illustrate the dynamics of FA changes between the genotypes over time. Black triangles represent the mean value from transgenic ArcAmice; gray circles represent the mean value from
wild-type controls. Error bars represent1 SD. Statistics for each effect is shown under the plot for the significant effects.
Figure 7. Immunohistological detection of A peptides ArcA transgenic mice at 2, 5, 11, and 21 months, and wild-type
control reveal sparse amyloid plaques at 5monthswith increasing plaque load at 11 and 21months (a). ROI analysis of the cortical
areas was used to estimate the surface occupied by the amyloid plaques at 11 and 21months (b). Correlation analysis indicate no
apparent link between amyloid plaque surface occupancy and functional connectivity for the corresponding regions (c; r 0.08).
Error bars represent1 SD. Scale bar, 1 mm.
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different transgenic lines may highlight salient features necessary
and sufficient to alter neuronal networks.
A potential confound in the study of FC in rodents is interfer-
ence by anesthesia. Although it has been reported that rats could
be trained to undergo fMRI sessions in awake state (Liang et al.,
2011), FC studies have been reported as being difficult to apply in
mice due to difficulties in acclimating the animals (Jonckers et al.,
2013). However, FC pattern in isoflurane anesthetizedmice were
shown to be strikingly similar to those recorded in the awake state
(Jonckers et al., 2013). All anesthetics interact with neurotrans-
mitter systems, which might be affected in a differential way in
different mouse lines. For example the GABAergic system, being
a target of several anesthetics including isoflurane (Kotani and
Akaike, 2013), appears to be affected by amyloid toxicity already
in early life of transgenic animals of cerebral amyloidosis (Krantic
et al., 2012). Hence, isoflurane anesthesia may exacerbate the
effects of amyloidosis in fMRI studies in these animals. We nev-
ertheless decided to use this anesthetic as it apparently preserves
cortical connectivity to a large extent when compare with the
awake state (Jonckers et al., 2013).
Alzheimer’s disease often involves amyloid deposition around
the vasculature (Weller et al., 1998), which inherently affects the
neurovascular coupling and potentially masks FC measured on
the basis of hemodynamic readouts, such as BOLD fMRI (Nico-
lakakis and Hamel, 2011) and intrinsic optical imaging (Bero et
al., 2012). A number of structural and functional consequences of
vasculopathy have been reported in murine models of amyloid-
osis, such as reduced cortical blood flow already early in life
(He´bert et al., 2013), as well as damaged capillary systems (Meyer
et al., 2008). The ArcA model displays vascular pathology at a
young age (Merlini et al., 2011) leading in old animals to cerebral
microbleeds (Klohs et al., 2011), impaired vascular reactivity
(Princz-Kranz et al., 2010), and vascular remodeling (Klohs et al.,
2012). As a result, it remains unclear whether the FC alterations
in thesemice are of neural or vascular origin, or both. A potential
contribution of altered neurovascular coupling should also be
considered when interpreting functional impairments in AD pa-
tients as derived from fMRI studies, as a significant fraction of
these patients is affected by severe vasculopathy (Castellani et al.,
2004).
Interestingly, the impaired development of FC in transgenic
animals during the 1–5 month period is also reflected by an al-
tered FA evolution in specific white matter structures, which
may, suggest a neuronal rather than vascular basis for the func-
tional changes. FA evolution during the first months of life has
been related to maturation of myelination in rats (Mengler et al.,
2014). Diffusion tensor imaging in the APP/PS1model revealed a
FA difference map overlapping with our results, including in-
creased FA in the minor forceps (Shu et al., 2013). The animal
data differ from patterns of FA changes in patients with AD,
where regionsmarked by reduced FA include the temporal lobes,
hippocampus, posterior cingulum and occipital lobe (Stebbins
and Murphy, 2009).
The dynamics of alteration, both spatial and temporal, differ
from patterns observed in AD patients, which is marked with
early altered FC in the default mode network and aggravated FC
in the transition from mild cognitive impairments to AD (Gre-
icius et al., 2004; Rombouts et al., 2005; Sorg et al., 2007; Sheline
et al., 2010a,b). The discrepancy in regional FC impairments be-
tween mice and human might be related to a link between neu-
ronal activity and A release affecting FC strength and amyloid
deposition in later life (Bero et al., 2011, 2012). Although, in
humans, theDMN is themetabolicallymost active network in the
brain at rest (Raichle et al., 2001), the somatosensory cortex ap-
pears as metabolically active as the cingulate in mice (Nicholson
et al., 2010). In fact, FC involving somatosensory ROIs shows the
highest correlation coefficients in our study, supporting the hy-
pothesis linking high brain activity to A pathology.
Another discrepancywith regards to human pathological pro-
gression related to the marginal decline in FC in ArcA mice
between 5 and 21 months of age despite massively increasing
amyloid plaque load, consistent with the dissociation between
amyloid load and connectivity (Adriaanse et al., 2014), but in-
consistent with the observed aggravation of FC associated with
transition frompreclinical to clinical AD (Rombouts et al., 2005).
The changes observed suggest an impaired functional and struc-
tural network maturation in ArcA, however the biological
mechanisms underlying the phenomenon remain elusive due to
themany effects attributed to elevated A peptide concentration.
Mechanisms might involve altered LTP (Knobloch et al., 2007a),
axonmisguiding (Cao et al., 2012), and/or alterations in cerebral
calcium homeostasis (Kuchibhotla et al., 2008).
In conclusion, we have shown using rs-fMRI that in the
ArcA transgenic mouse model of cerebral amyloidosis that the
development of FC during the first months of life is impaired as
compared with age-matched wild-type mice, with effects being
most pronounced for FC involving ROIs in the somatosensory
and motor cortex. Changes in FC are among the earliest detect-
Figure 8. Reproducibility of functional connectivity assessment was evaluated by comparing the coefficients of correlation of the results in the two rs-fMRI sessions recorded at 1 week intervals
for every animal at a given age (a). Reproducibility ranged between r 0.4 and r 0.58 between the cortical regions pairwise correlation, and0.01 to 0.2 in the subcortical interactions.
Intersessionmean and difference is shown for themedial parietal cortex pairwise correlation, illustrating the reproducibility of themeasure in cortical regions (b). The tSNR is shown per age group
and genotype, and indicates a peak at 2 and 21 months, with tSNR values ranging between 105 and 169 (c). Error bars represent 1 SD.
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able feature in cerebral amyloidosis, both in human and animal
models; however, the diagnostic value of this readout is ham-
pered by poor reproducibility at the individual level. This re-
mains a caveat of the method, which requires large groups of
animals/patients or large effects to properly power future studies.
Effects on FC are paralleled by structural changes as derived from
analysis of the FA of water diffusion, and occur in the early amy-
loid plaque buildup stage. Several factors may explain the ob-
served alteration, including defective maturation of both FC and
FA, reduced synaptic activity, or impaired cerebrovascular sys-
tem. The variety of transgenic models of cerebral amyloidosis
offers an experimental platform to elucidate features necessary
and sufficient to alter neuronal networks, to study the effects of
disease modifying agents, and to bridge mechanistic information
at a molecular and cellular level to functional/physiological read-
outs obtained at the system level, that can be ultimately translated
to neuroimaging studies in humans.
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